Devyser Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 09, 2023 at 06:30 am
Devyser Diagnostics AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 46.7 million compared to SEK 31.2 million a year ago. Net loss was SEK 6 million compared to SEK 8.8 million a year ago. Basic loss per share from continuing operations was SEK 0.37 compared to SEK 0.55 a year ago. Diluted loss per share from continuing operations was SEK 0.37 compared to SEK 0.55 a year ago.
For the nine months, sales was SEK 123.9 million compared to SEK 92.4 million a year ago. Net loss was SEK 40.5 million compared to SEK 29.3 million a year ago. Basic loss per share from continuing operations was SEK 2.51 compared to SEK 1.84 a year ago. Diluted loss per share from continuing operations was SEK 2.51 compared to SEK 1.84 a year ago.